Greg Watts

Medical Liaison with a 25-year track record of success in the Pharmaceutical industry. Proven ability to develop relationships and influence targeted KOLs across Allergy-Immunology, Pulmonology, Ophthalmology, Cardiovascular, Metabolic, and Urological disease states. Highly motivated; thrives in both individual and team environments; earns consistent respect from field sales forces and home office leadership.

Medical Liaison - ARS Pharmaceuticals Inc. - UT; ID; WA; OR; CA; HI; AK

(2025-05)

• Built key relationships with KOLs, Thought Leaders, and Academia Directors throughout the West.
• Lead representative at AAAAI in Philadelphia, PA (2/2025); played an integral role at the College Allergy Conference in Orlando, FL (11/2025).
• Attended and participated in poster sessions for neffy and clinical data; active in over 12 conferences in 2025.
• Presented scientific slides to nurse programs, KOLs, and academic centers, including UCLA, USC, the University of Utah, Alaska Medicaid, and Nevada Medicaid.
• Speaker for "Deep Dive into Anaphylaxis" webinar programs; trained speakers company-wide; participates in monthly Journal Clubs.
• Product: Neffy

Medical Liaison - OysterPoint Pharmaceuticals - UT; ID; WA; OR

(2021-09 - 2025-04)

• Served as a strong patient advocate; increased disease awareness and supported resource programs across the region.
• Developed and managed relationships with KOLs and medical thought leaders; acted as an ophthalmology expert at key medical and scientific conferences.
• Trained speakers and established relationships with key IDNs, including Intermountain Healthcare, Moran Eye Center/University of Utah, St. Luke's Health System, Eye Institute/UW Medicine, and Oregon Eye Institute in Eugene, OR.
• Researched and communicated the latest treatment options and highest standards of care.
• Product: Tyrvaya

Systems Director, Intermountain Healthcare IDN - AstraZeneca Pharmaceuticals Inc.

(2014-07 - 2021-08)

• Collaborated closely with KOLs in Cardiovascular and Endocrine therapeutic areas; led Speaker Programs with KOLs Dr. Muhlestein, Dr. Jeff Anderson, Dr. Miner, Dr. Merideth, and Dr. Kent Jones.
• Drove patient adherence through telecommunication reminder programs; coordinated Cardiology Health Fairs, Conferences, and Cardiology Updates across the IDN.
• Products: Crestor; Brilinta; Farxiga

Medical Liaison - Watson Pharmaceuticals - UT; ID; NV; MT

(2011-11 - 2014-06)

• Co-created the core scientific platform and messaging for marketing and sales; partnered in the development of sales force training materials and clinical speaker presentations.
• Engaged national and regional thought leaders in Urology in discussions of emerging therapies and basic science research; drove investigator-initiated research proposals from approval through abstract creation.
• Organized and participated in company-sponsored advisory board meetings; assisted field sales teams with targeted physician discussions.

Medical Science Liaison, CVRM / Hospital Cardiovascular Sales - AstraZeneca Pharmaceuticals Inc.

(2000-09 - 2011-10)

• Identified and cultivated relationships with physicians, NPs, PAs, clinical pharmacists, and large group practices; conducted educational programs on disease states and appropriate product use with a focus on diabetes, CKD, and CV areas.
• Developed long-term peer-level relationships with national and academic KOLs; contracted and influenced P&T committee members at Intermountain Healthcare.
• Delivered managed care and Medicaid presentations; coordinated speaker programs and symposia; trained new speakers across regional therapeutic areas.
• Products: Crestor; Onglyza; Brilinta; Toprol XL; Zestril; Atacand

Medical Diploma - St. Mary's Medical School (2000)

B.S. - Exercise Science - Utah State University (1994)